Abeona Therapeutics Inc. (ABEO) Q1 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Greetings. Welcome to Abiona Therapeutics' full year 2020 for results and business update conference call. At this time, all participants are in a listen-only mode. A question and answer session will follow the formal presentation. If anyone should require operator assistance during the conference, please press star zero on your telephone keypad. Please note this conference is being recorded. I will now turn the conference over to your host, Greg Chin, VP of Investor Relations and Communications at Abiona. Greg, you may begin. Thank you, Paul. Good morning and thank you for joining us on our full year 2024 results and business update conference call. During this call, we will refer to the press release issued this morning announcing the financial results. It's available on our corporate website at www.abionatherapeutics.com. Remarks made during today's call may contain projections and forward-looking statements, which are made pursuant to the safe harbor provisions of the federal securities laws. These forward-looking statements are based on current expectations and are subject to change. Actual results may differ materially from those expressed or implied in the forward-looking statements. Various factors that could cause actual results to differ include, but are not limited to, those identified under the risk factors section in our Form 10-K and periodic reports filed with the Securities and Exchange Commission. These documents are available on our website at www.avionatherapeutics.com. On the call today with prepared remarks are Dr. Vish Seshadri, Chief Executive Officer, Dr. Madhav Vasantavada, Chief Commercial Officer and Head of Business Development, Dr. Brian Keveny, Chief Technical Officer, and Joe Vizzano, Chief Financial Officer. And with that, I will now t...